tirzepatide and semaglutide for weight loss vs Weight loss: Semaglutide or tirzepatide,

In the most directly relevant comparator with semaglutide, MASH resolution was achieved in 62.9% of patients on the drug while fibrosis improvement reached only 36.8%, leaving substantially less overlap than the headline numbers might imply [16]

This isn't a blip

Nausea occurs at a similar rate to Wegovy (about 44% ), but vomiting ( 15% ) and GERD ( 6% ) were less common in clinical trials than with Wegovy

Retatrutide vs Ozempic : Retatrutide may outrun Ozempic in weight loss

For most people, oral supplementation between 5002000 mg per day is sufficient, while injections offer faster results with proper medical guidance